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Background: It is well known that maternal smoking during pregnancy is very harmful to the fetus. Prenatal
nicotine absorption, in particular, is associated with alterations in lung development and functions at birth and with
respiratory disorders in infancy. Many of the pulmonary disorders are mediated by the interaction of nicotine with
the nicotinic receptors (nAChRs), above all with the α7 nAChR subunits that are widely expressed in the developing
lung. To determine whether the lung hypoplasia frequently observed in victims of sudden fetal and neonatal death
with a smoker mother may result from nicotine interacting with lung nicotinic receptors, we investigated by
immunohistochemistry the possible presence of the α7 nAChR subunit overexpression in these pathologies.
Methods: In lung histological sections from 45 subjects who died of sudden intrauterine unexplained death syndrome
(SIUDS) and 15 subjects who died of sudden infant death syndrome (SIDS), we applied the radial alveolar count (RAC)
to evaluate the degree of lung maturation, and the immunohistochemical technique for nAChRs, in particular for the
α7 nAChR subunit identification. In the same cases, an in-depth study of the autonomic nervous system was performed
to highlight possible developmental alterations of the main vital centers located in the brainstem.
Results: We diagnosed a “lung hypoplasia”, on the basis of RAC values lower than the normal reference values, in 63%
of SIUDS/SIDS cases and 8% of controls. In addition, we observed a significantly higher incidence of strong α7 nAChR
immunostaining in lung epithelial cells and lung vessel walls in sudden fetal and infant death cases with a smoker
mother than in age-matched controls. Hypoplasia of the raphe, the parafacial, the Kölliker-Fuse, the arcuate and the
pre-Bötzinger nuclei was at the same time present in the brainstem of these victims.
Conclusions: These findings demonstrate that when crossing the placenta, nicotine can interact with nicotinic
receptors of both neuronal and non-neuronal cells, leading to lung and nervous system defective development,
respectively. This work stresses the importance of implementing preventable measures to decrease the noxious potential
of nicotine in pregnancy.
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Table 1 Case profiles of the study
Sudden perinatal deaths Controls
SIUDS SIDS Fetuses Newborns
No. cases 45 15 16 8
Sex (M/F) 28/17 10/5 9/7 4/4
Age (range) 32-41 gw 2 h-27 d 33-40 gw 2 h-25 d
Maternal smoking 20 7 1 4
d = days; gw = gestational weeks; h = hours.
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Maternal smoking during pregnancy has been associated
with intrauterine growth retardation, low birth weight,
neonatal morbidity and mortality, as well as an increased
incidence of respiratory disorders and of an attention
deficit in infants [1-6]. Nicotine, among thousands of
compounds of tobacco smoke, is particularly involved
in these pathological manifestations because, in cases
of prenatal exposure, it readily crosses the placental
barrier, so that levels of nicotine in the developing fetus
closely mimic and also exceed the maternal levels [7].
Fetal damage caused by maternal smoking mainly result
from the interaction of nicotine with nicotinic acetylcholine
receptors (nAChRs) [8-10]. These receptors are ion chan-
nels in the cytoplasmic membrane consisting of a different
combination of α and β subunits that can be opened not
only by the neurotransmitter acetylcholine but also by nico-
tine – hence the name “nicotinic”. To date, a total of 10α
and 4β different subunits have been described on the basis
of the receptors sensitivity to nicotine [11].
It is well known that nAChRs regulate critical aspects of
brain maturation during the intrauterine and early postna-
tal periods, mediating the neurochemical transmission of
acetylcholine among the neurons [12-15]. Prenatal nico-
tine exposure significantly increases nAChR endogenous
activation, above all in neuronal nuclei and/or in struc-
tures undergoing major phases of differentiation, that are
consequently more sensitive to environmental stimuli.
The knowledge of the biology of nAChRs has expanded
in recent years thanks to the identification of the nAChRs
also in several peripheral organs, including the lungs
[16,17]. Although the origin of lung damage caused by
maternal smoking in pregnancy is likely multifactorial,
many respiratory diseases may be mediated by the
interaction of nicotine with the nicotinic receptors that
are widely expressed in the airway cells of the developing
lung [18]. In this scenario, the expression of nAChR
provides a receptor-mediated mechanism that may help to
understand, at the molecular level, how smoking affects
lung development and leads to the well-documented de-
creased pulmonary function and increased respiratory
symptoms observed in exposed infants after birth. Sekhon
et al. [19,20], in experimental studies using specific anti-
bodies for different nAChR subunits (e.g., α3, α5, α7, β2),
demonstrated a marked α7 immunostaining intensity,
related to prenatal nicotine exposure, particularly in
the airway epithelial cells and airway vessel walls of
fetal and newborn lungs of monkeys. This means that
nicotine absorption mainly upregulates the pulmonary
expression of α7 nAChR, while other nicotinic receptor
subtypes are more resistant. In addition, these authors in-
dicated an association between α7 overexpression and an
altered airway development, with a subsequent influence
on respiratory health.Previously, we have reported a high incidence of lung
hypoplasia in subjects who died of Sudden Intrauterine
Unexplained Death Syndrome (SIUDS) and Sudden Infant
Death Syndrome (SIDS) [21,22]. In the present study we
aimed to investigate whether the lung hypodevelop-
ment frequently observed in these victims may be due,
as shown in experimental studies, to a specific hyper-
activation of the α7 nAChR subunit in cases of nicotine
absorption in pregnancy.
Methods
Among the many cases sent to our Research Center accord-
ing to the guidelines stipulated by the Italian law n.31/2006
“Regulations for Diagnostic Post Mortem Investigation in
Victims of SIDS and Unexpected Fetal Death”a and diag-
nosed as SIUDS and/or SIDS, we selected 60 cases, precisely
45 sudden late fetal deaths (32–39 gestational weeks) and
15 sudden neonatal deaths (within the first month of life),
provided with completeness of data, namely a detailed
collection of clinical/environmental information, including
the maternal smoking habit.
Twenty-seven mothers of the SIUDS/SIDS group (45%)
claimed to smoke before and during pregnancy, while the
remaining 32 (55%) denied they smoked.
We included in the study a control group consisting of
24 age-matched subjects (16 fetuses and 8 newborns) in
which the autopsy established a precise cause of death
(specifically, respiratory infections, cardiomyopathies, sep-
sis in infant deaths; cardiomyopathies and chorioamnionitis
in fetal deaths). Five of the 24 mothers of the control group
(21%) reported a smoking habit, while 19 mothers (79%)
were non-smokers.
Table 1 summarizes the case profiles of the study.
Consent
Parents of all the victims of the study provided written
informed consent to autopsy, with the Milan University
“Lino Rossi” Research Center institutional review board
approval.
A complete autopsy examination was carried out in
every case including, in particular, an in-depth study of
the brainstem and of the lungs. All organs were fixed in
10% phosphate-buffered formalin, processed and embedded
in paraffin.
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The brainstem was examined according to the protocol
routinely applied in the “Lino Rossi” Research Center,
available in our previous works [23,24] and in the web
site http://users.unimi.it/centrolinorossi/en/guidelines.html.
The routine histological evaluation of the brainstem was
focused on the main nuclei checking the vital functions:
the locus coeruleus, the Kölliker-Fuse and the rostral
raphe nuclei (magnum and caudal linear nuclei) in the
rostral pons/caudal mesencephalon; the retrotrapezoid,
the parafacial, the superior olivary and the median raphe
nuclei in the caudal pons; the hypoglossus, the dorsal
motor vagus, the tractus solitarius, the ambiguus, the pre-
Bötzinger, the inferior olivary, the arcuate, the obscurus
and the pallidus raphe nuclei in the medulla oblongata.
In addition we performed a morphometric analysis of
the main nuclei with an Image-Pro Plus Image Analyzer
(Media Cybernetics, Silver Spring, Maryland, USA) in
serial histological sections. The following parameters
were evaluated for every nucleus: neuronal density,
(number of neurons per unit area-mm2) and volume. All
the neurons with clearly defined edges and with a distinct
nucleolus were counted using an optical microscope at
20× magnification. The volume was measured by three-
dimensional reconstruction. A computer program de-
veloped by Voxblast (VayTek, Fairfield, Iowa) was used
to digitize and display serial section reconstructions, to
obtain volumetric measurements. The morphometric
results were expressed as mean values and standard devi-
ation. The statistical significance of direct comparisons be-
tween morphometric values obtained from sudden death
cases and controls was determined using the analysis of
variance. A diagnosis of hypoplasia related to a particular
nucleus was formulated when its morphometric values
were significantly lower than the reference values obtained
from age-matched control cases.
Lung examination
Regarding the lung examination, the main focus of the
study, samples were obtained from each lobe by cutting
parallel to the frontal plane and passing through the hilus.
The histological examination of the routinely stained sec-
tions by hematoxylin-eosin included the evaluation in ter-
minal lung units (i.e., portions of parenchyma distal to the
last respiratory bronchioles, identifiable by an incomplete
epithelial lining) of the radial alveolar count (RAC). This is
a reliable index of lung maturation in intrauterine and early
postnatal development established by Emery and Mithal in
1960 [25], closely related to the gestational age in weeks for
fetuses and to the postnatal age in months for newborns.
The RAC is obtained by examining at least 10 random
histological fields for each case in order to estimate the
number of airspaces cut by a straight line drawn from the
center of the most peripheral bronchiole to the nearestconnective tissue septum or the pleura. Emery and
Mithal also provided the RAC reference values at differ-
ent ages. The normal mean value from 32 to 35 gesta-
tional weeks is 3.2 ± 0.9; from 36 to 39 gestational weeks
3.6 ± 0.9. The normal RAC from the first postnatal
weeks to 4 months is 5.5 ± 1.4.
nAChR immunohistochemistry
Immunohistochemical methods were applied to selected
histological sections of lungs in order to evaluate the ex-
pression of α7 nAChRs by using specific rabbit polyclonal
antibodies (aa 22–71, Abcam cod. ab10096). Sections,
after dewax and rehydration, were immersed and boiled in
a Citrate Buffer solution pH 6.0 (for α3) and in TRIS-
EDTA Buffer (for α7 and β2) for the antigen retrieval with
a microwave oven, having first blocked endogenous perox-
idase by 3% hydrogen peroxide treatment. Then, sections
were incubated with the primary antibodies overnight
(diluitions: 1:75 for α3, 1:500 for α7 and 1:167 for β2) in a
wet chamber. Samples were washed with PBS buffer and
incubated with a secondary anti-rabbit antibody and then
processed with a usual avidin-biotin-immunoperoxidase
technique (VECTOR LABS, Burlingame, CA). Finally
each section was counterstained with Mayer’s Hematoxylin
and coverslipped.
A set of sections from each group of the study was used
as negative control. Precisely, the tissue samples were
stained using the same procedure but omitting the primary
antibody in order to verify that the immunolabeling was
not due to nonspecific labeling by the secondary antibody.
In fact, if specific staining occurs in negative control tissues,
immunohistochemical results should be considered invalid.
nAChR immunohistochemistry quantification
The degree of positive immunoreactivity in the lungs was
defined for every case by two independent and blinded
observers as the number of cells with strong unequivocal
immunostaining, divided by the total number of consecu-
tive cells counted in the epithelium surrounding both al-
veoli and bronchioles or divided by the total number of the
counted cells in the parenchima, expressed as percentage
(nAChR index: nAChR-I). nAChR-I was classified as: “Class
0” for no staining (negativity); “Class 1” when the index
was < 10% (weak positivity); “Class 2” with a percentage of
immunopositive cells between 10 and 30% (moderate
positivity); “Class 3” with an index > 30% of the counted
cells (strong positivity).
Comparison among the observations carried out by the
two pathologists was performed employing Kappa statistics
(Kappa Index- KI) to evaluate inter-observer reproducibil-
ity. The Landis and Koch [26] system of KI interpretation
was used, where 0 to 0.2 is slight agreement, 0.21 to
0.40 indicates fair agreement, 0.41 to 0.60 is moderate
agreement, 0.61 to 0.80 is strong or substantial agreement,
Figure 1 Histological section of lung parenchima showing the
radial alveolar count (RAC) method. SIDS case, 1 month-old
(RAC: 2.5; normal mean value for age: 5.5 ± 1.4). Hematoxylin-eosin
stain; magnification: 10×.
Figure 2 Positive α7 nAChR expression in a group of cells of
lung parenchyma – SIUDS case, 38 gestational weeks. α7 nAChR
immunostain; magnification: 20×.
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agreement (a value of 1.0 being perfect agreement).
This analysis revealed a very satisfactory Kappa Index
(KI = 0.85).
Markers for fibroblasts and collagen
– Immunostaining procedures for Fibroblast-specific
protein-1 (FSP-1; 11 kD) of the S100 superfamily
were applied to identify fibroblasts in the lung vessel
walls. Skin samples were used as positive controls;
negative controls were prepared omitting the
primary antibody and replacing only with PBS
during incubations. Sections from paraffin-embedded
tissue blocks were treated using commercially
supplied 1:400 diluted rabbit monoclonal antibodies
FSP-1 (Millipore #07-2274). Slides were boiled for the
antigen retrieval in 0.01 M citrate buffer (pH 6.0),
using a microwave oven, at 600 W for 3 times at
5 min each, and finally cooled. A standard ABC
technique avidin-biotin complex (Vectastain elite
ABC KIT, PK-6101) was used with HRP-DAB to
visualize and develop the antigen-antibody reaction.
Sections were counterstained with Mayer’s
hematoxylin, than coverslipped.
– Heidenhain’s trichrome staining (AZAN staining) was
applied as histochemical staining procedure to
identify the collagen around the airways and the
vessels. In this method three acid dyes are used:
azocarmine and a mixture of aniline blue and orange
G. The azocarmine stain is combined with the
mixture of aniline blue and orange G as counterstain,
after mordanting with phosphotungstic acid. The
collagen and cytoplasmic reticulum appear blue,
muscle red to yellow, nuclear chromatine red.
Statistical analysis
Histological and immunohistochemical data were tabu-
lated and analyzed for differences comparing pairs of
groups by using the analysis of variance (ANOVA).
Statistical calculations were carried out with a SPSS sta-
tistical software (version 11.0; SPSS Inc., Chicago, IL,
USA). The selected threshold level for statistical signifi-
cance was p < 0.05.
Results
Lung examination in SIUDS/SIDS
Histology
In 38 cases (63%) of sudden death (33 SIUDS and 5 SIDS),
a paucity of pulmonary alveoli was highlighted in histo-
logical sections demonstrating lower radial counts than
the normal reference values (Figure 1). The mean RAC
value was 2.1 ±0.4 in 12 fetuses aged 32–35 gws (normal
value: 3.2 ± 0.9), and 2.7 ± 0.2 in 21 fetuses aged 36–39gws (normal value: 3.6 ± 0.9), while the mean RAC value
in the 5 newborns (aged from 1 to 3 postnatal months)
was 3.0 ± 0.5 (normal value: 5.5 ± 1.4). These observations
supported the diagnosis of “lung hypoplasia”.nAChR expression
Examination of the immunostained preparations revealed
a strong immunoreactivity for the nAChR α7 subunit
(“Class 3” of nAChR-I) in densely packed cells of com-
pact lung parenchyma areas (Figure 2) and in epithelium
surrounding both alveoli and bronchioles (Figure 3) in 22
SIUDS and 8 SIDS victims. In these cases an intense α7 im-
munoreactivity was also frequently expressed in fibroblasts
of the airway and vessel walls (Figure 4). The vascular
walls, in particular, appeared thick due to the increase
of connective tissue, as demonstrated by the intense
histochemical positivity for the collagen and the positive
immunostaining for fibroblasts (Figure 5).
Figure 3 Positive α7 nAChR epithelial cells surrounding in A) the lumen of an alveolus and in B) the lumen of a bronchiole – SIDS
case, 2 month-old. α7 nAChR immunostain; magnification: 40×.
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Histology
Mostly, in control subjects the RAC was within the nor-
mal reference values. Nevertheless, a “low grade of lung
hypoplasia” in 2 newborns (8%) who died of pneumonia in
the first two months of life, with a slightly lower lung
maturation index than the mean value for the age (RAC
value: 4; mean reference value: 5.5 ± 1.4).nAChR expression
A high α7 subunit immunoreactivity (“Class 3” of
nAChR-I) was detected in the airway epithelium of 3
newborns, two of whom had died of respiratory infec-
tions and showed mild lung hypoplasia.Correlation of lung observations with maternal smoking
A significant association between a strong expression
of α7 nAChR, lung hypoplasia and prenatal cigarette
smoke exposure (p < 0.01) occurred. In fact, 20 of the
27 cases with a smoker mother belonged to the SIUDS/
SIDS group showing a high α7 immunopositivity and
lower RAC values than the reference values. Moreover,
the mothers of the 3 control infants with similar nAChR
results and mild lung hypoplasia were active smokers
in pregnancy.Figure 4 Positive α7 nAChR in the wall of pulmonary vessels (see arro
magnification in B) – SIUDS case, 38 gestational weeks. α7 nAChR immuBrainstem examination in SIUDS/SIDS and controls
The in-depth histological examination, supported by the
morphometric analysis, of the brainstem in SIUDS/SIDS
cases frequently yielded a diagnosis of hypodevelopment
of important nuclei and/or neuronal structures check-
ing vital functions. Hypoplasia/agenesis of one or more
nuclei of the raphe system (i.e., obscurus, pallidus, me-
dian, magnum, caudal linear raphe nuclei), a complex
of nuclei that plays a trophic role in brain develop-
ment, being responsible for serotonergic transmission
[27], was the most frequent alteration (observed in 28
SIUDS and 8 SIDS).
In 11 SIUDS with hypoplasia of the obscurus and pal-
lidus raphe nuclei in the medulla oblongata, we observed
an association with hypoplasia of the pontine parafacial
and Kölliker-Fuse nuclei, consisting of “pre-inspiratory”
neurons with the hierarchical function of starting the
first breathing movements [28,29].
Hypoplasia of the medullary pre-Bötzinger nucleus, a
critical structure for respiratory rhythmogenesis [30],
and of the arcuate nucleus, involved in chemorecep-
tion [31], was simultaneously present in 12 SIUDS and
6 SIDS victims, five of whom showed agenesis of the
raphe obscurus nucleus.
In most of these cases (15 SIUDS and 4 SIDS) the mother
smoked during pregnancy.ws). One of the two vessels shown in A) is represented at higher
nostain; magnification: A) 10×; B) 40×.
Figure 5 Identification of pulmonary perivascular fibroblasts and collagen. A) identification of fibroblastic cells around a lung vessel by
FSP-1 immunohistochemistry (brown reaction product). B) Perivascular blue collagen fibers highlighted by histochemistry – SIDS case,
2 month-old. A) FSP-1 immunostain; magnification: 20x - B) AZAN stain; magnification 20×.
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pathological results and the above-reported lung alterations.
In fact, in 20 SIUDS and 4 SIDS victims with a defective
maturation of important brainstem centers, lung hypoplasia
with a high α7 nicotinic receptor expression was discovered.
In controls hypoplasia of the arcuate nucleus was the
only finding (observed in 3 cases), not related to maternal
smoking. On the whole, SIUDS and SIDS cases displayed
a significantly higher incidence of brainstem pathological
findings as compared to age-matched controls (p < 0.01).
Table 2 summarizes the anatomopathological and im-
munohistochemical results obtained in this study.
Further research aimed at evaluating nicotinic receptor





Lung hypoplasia n.33 (73%)**
RAC (mean value)
Age Reference value
32-35 gw 3.2±0.9 2.1±0.4
36-39 gw 3.6±0.9 2.7±0.2
1-3 pm 5.5±1.4 -
α7 nAChR strong immunopositivity n.22 (49%)**
Brainstem pathology






gw= gestational weeks; pm= postnatal months; RAC= radial alveolar count.
(1)Individual victims may display any combination of brainstem alterations.
Statistical significant differences (SIUDS and SIDS vs. corresponding controls): *= p<laboratory, and will be the subject of a forthcoming
publication.
Discussion
The lung, during its long process of maturation from the
embryonic phase of development in utero up to adoles-
cence, is highly susceptible to damage caused by ex-
posure to environmental toxicants, and particularly to
tobacco smoke in pregnancy [32-34].
In pregnant smokers nicotine, that in amniotic fluid
reaches similar or higher levels than those present in ma-
ternal plasma [7], when crossing the placenta can directly
affect fetal lung development. This is facilitated by the fact
that the metabolic activity of the fetal liver is not yet welln perinatal deaths Controls
SIDS Fetuses Newborns
n.15 n.16 n.8





n.8 (53%)* n.0 (0%) n.3 (37%)






0.05; **= p< 0.01.
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the ability to interfere in the development of especially
the most vulnerable organs, including the lung [35]. In
addition the developing lung can be exposed during
early childhood to nicotine ingestion through the breast
milk from a smoking mother [36].
Previous experimental studies performed on Rhesus
monkeys, an ideal model of pulmonary growth that is
very similar to that of humans, demonstrated that nicotine
administration during pregnancy causes lung hypodevelop-
ment as a direct result of its interaction with the α7 subunit
of the nicotinic receptors, that are widely distributed in the
airways epithelium in prenatal life [19]. Similar results
were more recently obtained by Wongtrakool et al. [37] in
mouse. These authors established that prenatal nicotine
exposure leads to a decrease in pulmonary function and in
alveolar surface, through interactions with α7 nAChRs.
The involvement of this specific subunit in lung patho-
physiology is also proven by its strong manifestation in
tobacco-induced cancers. Nicotine contributes directly
to pulmonary tumorigenesis through stimulation of the α7
nAChR subunits in target cells, as shown by their overex-
pression particularly in non-small cell lung carcinomas of
patients who smoked [38,39].
Basing on these results, we propose a potential molecular
mechanism responsible for the high incidence of lung
hypoplasia in SIUDS and SIDS whose mothers smoked.
We hypothesize that the overexpression of the α7 nico-
tinic receptors we found in these cases is the result of
modifications of the corresponding gene expression. This
is supported by the increased messenger RNA levels of
several nAChR subunits (including α7 subunits) observed
in the developing nervous system of rats as a consequence
of nicotine absorption [40], leading to a remarkable in-
crease in receptor protein synthesis. In human pulmonary
cell cultures, Plummer et al. [41] likewise demonstrated
a higher α7 mRNA and a consequent increase in α7 nic-
otinic receptor levels in the presence of nicotine-derived
carcinogenic nitrosamine.
In our study, the α7 nAChR overexpression observed in
lung epithelial cells in a high percentage of SIUDS/SIDS
victims was exacerbated by the presence of developmental
alterations of brainstem centers affecting not only breathing
activity but, more in general, all the vital functions, thus
amplifying the harmful effect of nicotine and leading to a
fatal outcome. The results of the current research now in
progress in our laboratory on the α7 nAChR expression in
the brainstem, will validate this assertion. It is therefore
clear that nicotine, after entering the fetal circulation and
crossing the fetal blood–brain barrier, interacts with the
α7 subunits and up-regulates its expression in both non-
neuronal cells of the lung and in neuronal cells of the
brainstem, thereby leading to impaired lung function and
hypodevelopment of the respiratory neuronal centers.The strong immunoexpression of the α7 nAChR sub-
unit also observed in fibroblasts around lung vessels
and airways must be underlined. The vascular walls, in
particular, appear thicker, very likely due to interactions of
nicotine with fibroblast receptors, thereby triggering a high
collagen protein synthesis and hence causing accumulation
of connective tissue. Nicotine can therefore directly stimu-
late α 7 nAChR-bearing fibroblasts to lay down an excessive
amount of connective tissue.
These considerations are consistent with the report by
Sekhon et al. [42] of a high expression of α7 subunits in
fibroblasts of the lung vessels in monkey fetuses exposed to
nicotine during pregnancy, with a significant accumulation
of collagen in the tunica media.
Collagen deposition around the airways and pulmonary
vessels certainly induces an increased airway resistance and
decreased respiratory function, providing an explanation
for the high incidence of persistent pulmonary hyperten-
sion observed in infants whose mothers smoked during
pregnancy [43].
It is important to point out several limitations of this
study. First, the exact mechanisms by which nicotine
interacts with nAChR to alter lung development remain to
be determined. This is due, in particular, to the impossibil-
ity to perform experimental studies in humans. However,
based on our results we can hypothesize a link between
α7 overexpression and delayed pulmonary development in
SIUDS/SIDS victims. Secondly, pertaining to cigarette
smoke exposure, is that available information on our cases
did not provide evidence of an exposure ‘dose’. Further-
more, it should be considered that retrospective assess-
ment of the maternal smoking, particularly if performed
after a fatal event, is sometimes unreliable, due to the fact
that mothers who smoke are reluctant to admit tobacco
use, because of feelings of guilt [44]. Finally, it is important
to point out that our study was focused on the role of the
increased α7 receptor expression in developing lung in
relation to nicotine absorption. Hovewer we detain
that other nAChR subtypes could likely play important
roles in mediating the effects of nicotine on lung devel-
opment. Therefore we plan to extend the study, using a
wider range of nAChRs.
Conclusions
This article emphasizes the extreme vulnerability of the
developing lung to maternal cigarette smoke absorption.
In summary, we claim that nicotine in pregnant women
is readily transported across the placenta, achieving
sufficient levels to interact directly with the nicotinic
receptors that are widely distributed in the lung cells
in prenatal life. In particular, on the basis of our results
and of previous experimental studies, we propose α7
nAChR as the main candidate mediating the pathobio-
logic effects of tobacco products on lung maturation
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ecules with α7 subunits, widespread in the cytoplasmic
membrane of both lung epithelial cells and fibroblasts,
leads to an overexpression of the corresponding receptors
with a consequent severe inhibition of airway development
in utero, as well as an airflow decrease in the first days of
life and a high incidence of smoke-associated pediatric
respiratory disorders. The relevance of this study is the
significantly higher association highlighted among many
factors (overexpression of α7 nAChRs, lung hypoplasia,
developmental alterations of brainstem nuclei and maternal
smoking) in SIUDS/SIDS, as compared to controls.
Despite the compelling evidence that prenatal nicotine
absorption increases the incidence of pulmonary diseases
in fetal and infant life, in addition to posing the well known
risks of spontaneous abortion, preterm delivery, low birth
weight and sudden perinatal death, a significant number of
women continue to smoke during pregnancy.
The findings of this study further underline the import-
ance of ensuring widespread information about the nox-
ious potential of nicotine absorption in pregnancy, as well
as the need to implement measures to prevent this major
and avoidable cause of lung morbidity and mortality in
fetuses and infants.
Endnote
aThis law decrees that all infants suspected of SIDS, sud-
denly died in Italian regions within the first year of age, as
well as all fetuses who died without any apparent cause
(SIUDS), must undergo an in-depth anatomo-pathological
examination, particularly of the autonomic nervous system.
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